Columnist Desiree Lama describes her journey with MS-related bladder problems that were brought under control but are now ...

Experts in Australia and New Zealand have published the first consensus guidelines for the care of adults with MS in those ...

Hormonal changes at puberty may trigger disease activity, but DMTs reduced the risk, indicating more aggressive treatment may be warranted.

Researchers suggest the persistent inflammation from obesity may enhance the detrimental effects of intermittent or sustained ...

Adults with relapsing MS rated the Sensoready pen, an autoinjector used to self-administer Kesimpta, for ease of use and ...

Severe obesity in childhood and adolescence more than triples the risk of MS, and obesity treatment does not seem to reverse ...

A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...

A Phase 2 clinical trial is currently recruiting adults with relapsing types of multiple sclerosis (MS) to investigate Zenas Biopharma’s experimental therapy obexelimab as a weekly subcutaneous ...

Severe obesity during childhood and adolescence more than triples the risk of developing multiple sclerosis (MS), and losing weight through early lifestyle changes did not decrease the likelihood ...

MS patient Lynda Whitton received MS Australia’s 2024 John Studdy Award in recognition of her advocacy, leadership, and ...